367 related articles for article (PubMed ID: 35683711)
21. Nanoparticles-Attractive Carriers of Antimicrobial Essential Oils.
Nair A; Mallya R; Suvarna V; Khan TA; Momin M; Omri A
Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052985
[TBL] [Abstract][Full Text] [Related]
22. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
[TBL] [Abstract][Full Text] [Related]
23. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems.
Imran M; Jha SK; Hasan N; Insaf A; Shrestha J; Shrestha J; Devkota HP; Khan S; Panth N; Warkiani ME; Dua K; Hansbro PM; Paudel KR; Mohammed Y
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335962
[TBL] [Abstract][Full Text] [Related]
24. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
[TBL] [Abstract][Full Text] [Related]
25. Infection microenvironment-related antibacterial nanotherapeutic strategies.
Wang Z; Liu X; Duan Y; Huang Y
Biomaterials; 2022 Jan; 280():121249. PubMed ID: 34801252
[TBL] [Abstract][Full Text] [Related]
26. Nanoliposome-based antibacterial drug delivery.
Hallaj-Nezhadi S; Hassan M
Drug Deliv; 2015; 22(5):581-9. PubMed ID: 24313827
[TBL] [Abstract][Full Text] [Related]
27. Recent Advances in Strategies to Combat Bacterial Drug Resistance: Antimicrobial Materials and Drug Delivery Systems.
Yao J; Zou P; Cui Y; Quan L; Gao C; Li Z; Gong W; Yang M
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111673
[TBL] [Abstract][Full Text] [Related]
28. Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update.
Shaikh S; Shakil S; Abuzenadah AM; Rizvi SM; Roberts PM; Mushtaq G; Kamal MA
Curr Drug Metab; 2015; 16(5):362-70. PubMed ID: 26419545
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.
Handa M; Beg S; Shukla R; Barkat MA; Choudhry H; Singh KK
J Control Release; 2021 Dec; 340():48-59. PubMed ID: 34695523
[TBL] [Abstract][Full Text] [Related]
30. Solid nanoparticles for oral antimicrobial drug delivery: a review.
Raza A; Sime FB; Cabot PJ; Maqbool F; Roberts JA; Falconer JR
Drug Discov Today; 2019 Mar; 24(3):858-866. PubMed ID: 30654055
[TBL] [Abstract][Full Text] [Related]
31. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
[No Abstract] [Full Text] [Related]
32. Advances in colon-targeted nano-drug delivery systems: challenges and solutions.
Naeem M; Awan UA; Subhan F; Cao J; Hlaing SP; Lee J; Im E; Jung Y; Yoo JW
Arch Pharm Res; 2020 Jan; 43(1):153-169. PubMed ID: 31989477
[TBL] [Abstract][Full Text] [Related]
33. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
Jain D; Rashid MA; Ahmad FJ
Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
[TBL] [Abstract][Full Text] [Related]
34. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A
J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621
[TBL] [Abstract][Full Text] [Related]
35. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
[TBL] [Abstract][Full Text] [Related]
36. Nanotechnology-based lipid systems applied to resistant bacterial control: A review of their use in the past two decades.
Dos Santos Ramos MA; de Toledo LG; Spósito L; Marena GD; de Lima LC; Fortunato GC; Araújo VHS; Bauab TM; Chorilli M
Int J Pharm; 2021 Jun; 603():120706. PubMed ID: 33991597
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial lipids in nano-carriers for antibacterial delivery.
Zhang Q; Wu W; Zhang J; Xia X
J Drug Target; 2020 Mar; 28(3):271-281. PubMed ID: 31613147
[TBL] [Abstract][Full Text] [Related]
38. Concepts on Smart Nano-Based Drug Delivery System.
Rai S; Singh N; Bhattacharya S
Recent Pat Nanotechnol; 2022; 16(1):67-89. PubMed ID: 33494685
[TBL] [Abstract][Full Text] [Related]
39. Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance.
Minakshi P; Ghosh M; Brar B; Kumar R; Lambe UP; Ranjan K; Manoj J; Prasad G
Curr Pharm Des; 2019; 25(13):1554-1579. PubMed ID: 31218956
[TBL] [Abstract][Full Text] [Related]
40. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
